WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography    

Custom CD of patents similar to US5137023 : Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography - $19.95
United States Patent5137023   
Link to this pagehttp://www.wikipatents.com/5137023.html
Inventor(s)Mendelson; Yitzhak (Worcester, MA); Peura; Robert A. (Princeton, MA); Harjunmaa; Hannu (Vessy, CH)
AbstractA non-invasive system for measuring the concentration of an analyte, such as glucose, in an absorbing matrix is described. The system directs beams of light at the matrix using an analyte sensitive wavelength and an analyte insensitive wavelength. The principles of photoplethysmography are applied to measure the change in light intensity caused by matrix absorption before and after the blood volume change caused by the systolic phase of the cardiac cycle. The change in light intensity is converted to an electrical signal which is used to adjust the light intensity and as a measure of analyte concentration.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 5137023
Method and apparatus for monitoring blood analytes noninvasively by

     pulsatile photoplethysmography - US Patent 5137023 Drawing
Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography
Inventor     Mendelson; Yitzhak (Worcester, MA); Peura; Robert A. (Princeton, MA); Harjunmaa; Hannu (Vessy, CH)
Owner/Assignee     Worcester Polytechnic Institute (Worcester, MA)
Patent assignment
All assignments
Company News
Publication Date     August 11, 1992
Application Number     07/511,229
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     April 19, 1990
US Classification     600/316 600/322 600/475
Int'l Classification     A61B 005/00
Examiner     Howell; Kyle L.
Assistant Examiner     Pontius; Kevin
Attorney/Law Firm     Hamilton, Brook, Smith & Reynolds
Address
Parent Case    
Priority Data    
USPTO Field of Search     128/632 128/633 128/634 128/664 128/666 356/39 356/40 356/41 250/215
Patent Tags     monitoring blood analytes noninvasively by pulsatile photoplethysmography
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
1758088



[0 after 0 votes]
2721942



[0 after 0 votes]
3463142



[0 after 0 votes]
5054487
Clarke
600/316
Oct,1991

[0 after 0 votes]
5028787
Rosenthal
250/339.12
Jul,1991

[0 after 0 votes]
4882492
Schlager
250/346
Nov,1989

[0 after 0 votes]
4832484
Aoyagi
356/41
May,1989

[0 after 0 votes]
4817623
Stoddart
600/477
Apr,1989

[0 after 0 votes]
4805623
Jobsis
600/328
Feb,1989

[0 after 0 votes]
4796636
Branstetter
600/330
Jan,1989

[0 after 0 votes]
4759369
Taylor
600/323
Jul,1988

[0 after 0 votes]
4750496
Reinhart
600/347
Jun,1988

[0 after 0 votes]
4725147
Stoddart
356/433
Feb,1988

[0 after 0 votes]
4704029
Van Heuvelen
356/39
Nov,1987

[0 after 0 votes]
4655225
Dahne
600/316
Apr,1987

[0 after 0 votes]
4653498
New, Jr.
600/324
Mar,1987

[0 after 0 votes]
4641658
Lepper
600/330
Feb,1987

[0 after 0 votes]
4621643
New, Jr.
600/331
Nov,1986

[0 after 0 votes]
4603700
Nichols
600/331
Aug,1986

[0 after 0 votes]
4586513
Hamaguri
600/326
May,1986

[0 after 0 votes]
4570638
Stoddart
600/476
Feb,1986

[0 after 0 votes]
4513751
Abe
600/479
Apr,1985

[0 after 0 votes]
4485820
Flower
600/320
Dec,1984

[0 after 0 votes]
4427889
Muller
250/339.11
Jan,1984

[0 after 0 votes]
4398541
Pugliese
600/476
Aug,1983

[0 after 0 votes]
4380240
Jobsis
600/344
Apr,1983

[0 after 0 votes]
4306877
Lubbers
436/166
Dec,1981

[0 after 0 votes]
4267844
Yamanishi
600/315
May,1981

[0 after 0 votes]
4266554
Hamaguri
600/323
May,1981

[0 after 0 votes]
4169676
Kaiser
356/39
Oct,1979

[0 after 0 votes]
4033330
Willis
600/366
Jul,1977

[0 after 0 votes]
4029085
DeWitt
600/315
Jun,1977

[0 after 0 votes]
3963019
Quandt
600/319
Jun,1976

[0 after 0 votes]
3958560
March
600/319
May,1976

[0 after 0 votes]
3926527
Pembrook
356/246
Dec,1975

[0 after 0 votes]
3638640
Shaw
600/323
Feb,1972

[0 after 0 votes]
4768516
Stoddart
600/474
Dec,1969

[0 after 0 votes]
4321930
Jobsis
600/344
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


We claim:

1. A method for determining the concentration of glucose in the blood of a body matrix which is subject to the systolic and diastolic phases of blood flowing through the matrix during the cardiac cycle, comprising the steps of:

a) generating a composite beam of electromagnetic radiation at each of two distinct wavelengths, a first such wavelength being glucose sensitive and a second such wavelength being glucose insensitive and wherein the two distinct wavelengths have the same matrix extinction in the body matrix and are in the infrared band of light;

b) directing said composite radiation at said matrix;

c) detecting said composite radiation after it has traversed a portion of said matrix; and

d) generating a composite electrical intensity signal proportional to the intensity of the detected composite radiation, which intensity signal is comprised of an alternating component produced by the variation in volume of blood flowing through the matrix and a non-alternating component produced by the non-varying portions of the matrix;

e) separating the composite electrical signal into a first channel signal consisting of that portion of the electrical signal produced by detecting radiation at said first wavelength and a second channel signal consisting of that portion of the electrical signal produced by detecting radiation at said second wavelength;

f) decomposing the first channel signal into a first alternating signal and a first non-alternating signal;

g) decomposing the second channel signal into a second alternating signal and a second non-alternating signal;

h) determining the amplitude ratio of the alternating to the non-alternating signal of each of the first and second channel signals;

i) generating an error signal from said ratio;

j) integrating the error signal to produce a control signal;

k) generating a difference signal proportional to the difference between said control signal and a reference signal; said difference signal representing the instantaneous glucose concentration in the matrix.

2. A method for determining the concentration of an analyte in the blood of a body matrix which is subject to the systolic and diastolic phases of blood flowing through the matrix during the cardiac cycle, comprising the steps of:

a) generating a composite beam of electromagnetic radiation at each of two distinct wavelengths, a first such wavelength being analyte sensitive and a second such wavelength being analyte insensitive;

b) directing said composite radiation at said matrix;

c) detecting said composite radiation after it has traversed a portion of said matrix; and

d) generating a composite electrical intensity signal proportional to the intensity of the detected composite radiation, which intensity signal is comprised of an alternating component produced by the variation in volume of blood flowing through the matrix and a non-alternating component produced by the non-varying portions of the matrix;

e) separating the composite electrical signal into a first channel signal consisting of that portion of the electrical signal produced by detecting radiation at said first wavelength and a second channel signal consisting of that portion of the electrical signal produced by detecting radiation at said second wavelength;

f) decomposing the first channel signal into a first alternating signal and a first non-alternating signal;

g) decomposing the second channel signal into a second alternating signal and a second non-alternating signal;

h) determining the difference between the value of the alternating and the non-alternating signal of each of the first and second channel signals;

i) from said difference, determining the concentration of analyte in the matrix.

3. The method of claim 2 wherein the analyte is glucose.

4. The method of claim 3 wherein the two distinct wavelengths have the same matrix extinction in the body matrix and are in the infrared band of light.

5. A method for determining the concentration of an analyte in the blood of a body matrix which is subject to the systolic and diastolic phases of blood flowing through the matrix during the cardiac cycle, comprising the steps of:

a) generating a composite beam of electromagnetic radiation at each of two distinct wavelengths, a first such wavelength being analyte sensitive and a second such wavelength being analyte insensitive and wherein the matrix extinction of the two wavelengths is the same in the body matrix;

b) directing said composite radiation at said matrix;

c) detecting said composite radiation after it has traversed a portion of said matrix; and

d) generating a composite electrical intensity signal proportional to the intensity of the detected composite radiation, which intensity signal is comprised of an alternating component produced by the variation in volume of blood flowing through the matrix and a non-alternating component produced by the non-varying portions of the matrix;

e) separating the composite electrical signal into a first channel signal consisting of that portion of the electrical signal produced by detecting radiation at said first wavelength and a second channel signal consisting of that portion of the electrical signal produced by detecting radiation at said second wavelength;

f) decomposing the first channel signal into a first alternating signal and a first non-alternating signal;

g) decomposing the second channel signal into a second alternating signal and a second non-alternating signal;

h) determining the amplitude ratio of the alternating to the non-alternating signal of each of the first and second channel signals;

i) from said ratio, determining the concentration of analyte in the matrix.

6. A method for determining the concentration of an analyte in the blood of a body matrix which is subject to the systolic and diastolic phases of blood flowing through the matrix during the cardiac cycle, comprising the steps of:

a) generating a composite beam of electromagnetic radiation at each of two distinct wavelengths, a first such wavelength being analyte sensitive and a second such wavelength being analyte insensitive and wherein the matrix extinction of the two wavelengths is the same in the body matrix;

b) directing said composite radiation at said matrix;

c) detecting said composite radiation after it has traversed a portion of said matrix; and

d) generating a composite electrical intensity signal proportional to the intensity of the detected composite radiation, which intensity signal is comprised of an alternating component produced by the variation in volume of blood flowing through the matrix and a non-alternating component produced by the non-varying portions of the matrix;

e) separating the composite electrical signal into a first channel signal consisting of that portion of the electrical signal produced by detecting radiation at said first wavelength and a second channel signal consisting of that portion of the electrical signal produced by detecting radiation at said second wavelength;

f) decomposing the first channel signal into a first alternating signal and a first non-alternating signal;

g) decomposing the second channel signal into a second alternating signal and a second non-alternating signal;

h) determining the difference between the value of the alternating and the non-alternating signal of each of the first and second channel signals;

i) from said difference, determining the concentration of analyte in the matrix.

7. A method for determining the concentration of glucose in the blood of a body matrix which is subject to the systolic and diastolic phases of blood flowing through the matrix during the cardiac cycle, comprising the steps of:

a) generating a composite beam of electromagnetic radiation at each of two distinct wavelengths, a first such wavelength being glucose sensitive and a second such wavelength being glucose insensitive and wherein the matrix extinction of the two wavelengths is the same in the body matrix;

b) directing said composite radiation at said matrix;

c) detecting said composite radiation after it has traversed a portion of said matrix; and

d) generating a composite electrical intensity signal proportional to the intensity of the detected composite radiation, which intensity signal is comprised of an alternating component produced by the variation in volume of blood flowing through the matrix and a non-alternating component produced by the non-varying portions of the matrix;

e) separating the composite electrical signal into a first channel signal consisting of that portion of the electrical signal produced by detecting radiation at said first wavelength and a second channel signal consisting of that portion of the electrical signal produced by detecting radiation at said second wavelength;

f) decomposing the first channel signal into a first alternating signal and a first non-alternating signal;

g) decomposing the second channel signal into a second alternating signal and a second non-alternating signal;

h) comparing the alternating to the non-alternating signal of each of the first and second channel signals;

i) from said comparison, determining the concentration of glucose in the matrix.
 Description Submit all comments and votes
 


BACKGROUND OF THE INVENTION

One the most common techniques for measuring blood glucose requires removal and subsequent analysis of a sample of the patients blood using reagent-strip reflectance photometry. This technique is still considered to be the most accurate method for obtaining an absolute reading of blood glucose. However, this technique is painful and also undesirable in cases